FHI Clinical tackles COVID-19 immunotherapy in clinical trial
The company is working with the Infectious Disease Research Institute on an immunotherapy clinical trial to combat the virus.
The company is working with the Infectious Disease Research Institute on an immunotherapy clinical trial to combat the virus.
The partnership aims to make decentralized trial solutions like remote monitoring, patient care, and clinical assessments more readily available.